The Elton John AIDS Foundation will honor its most notable supporters at the 15th annual An Enduring Vision gala, which will be hosted by Cipriani Wall Street in New York City on Nov. 2.

The American Heart Association (AHA) recently released a statement from its CEO, Nancy Brown, about how 'disappointed' the agency is with the ongoing fight against the sugary drink tax in Philadelphia.

The American Academy of Family Physicians (AAFP) and other health leaders recently joined a campaign to emphasize healthy aging for Americans this September.

GlaxoSmithKline (GSK) recently stated that its shingles vaccine candidate has been showing strong efficacy against shingles as well as its complications among adults who are 70 years old and above.

The University of St. Augustine for Health Sciences (USAHS), a top graduate institution that highlights rehabilitative and health science education with innovative classroom and distance education, recently earned a Platinum Fit-Friendly Worksite award from the American Heart Association (AHA).

Leaders with the U.S. Food and Drug Administration (FDA) recently approved of an additional indication for the Sapien 3 and Sapien XT transcatheter heart valves, designed for patients who have aortic valve stenosis.

A new report from the Alliance for Childhood Cancer and the American Cancer Society emphasizes the gaps and obstacles that face pediatric cancer research, showing that it is important to guarantee long-term health for pediatric cancer survivors.

According to the American Academy of Family Physicians (AAFP), the Agency for Healthcare Research and Quality (AHRQ) recently published the latest rankings showing the quality of health care in specific states.

Boston Mayor Martin Walsh and James Wessler, CEO of the Alzheimer’s Association, Massachusetts-New Hampshire Chapter, recently received the Alzheimer’s Readiness Award for their work to guarantee that Boston is prepared for the outcomes of Alzheimer’s disease.

XOMA Corporation, a top company in discovering and developing therapeutic antibodies, recently published an update about its ongoing XOMA 358 phase-two studies for hypoglycemia.

The Global Alzheimer’s Platform Foundation Inc. (GAP), a nonprofit agency focused on decreasing the duration, expense and risk of Alzheimer’s clinical trials, recently added Pascale Witz to the organization’s board of directors.

The U.S. Food and Drug Administration (FDA) recently took proactive measures to protect children from the illegal sale of e-liquids, e-cigarettes and cigars.

Patients suffering from chronic diseases are most worried -- outside of their illnesses -- about knowing how much they are going to pay and about access to services, according to a major survey published this week.

Officials with the U.S. Food and Drug Administration recently approved the VisuMax Femtosecond Laser, which is designed for small incision lenticule extraction (SMILE) procedures to decrease or end nearsightedness.

High profile cases of rising drug and medication prices are out of the ordinary and do not reflect what is broadly going on with health care spending, according to the chief economist and health care expert at a Washington, D.C.-based think tank.

Leaders with the American Diabetes Association (ADA) and Google recently developed a collaboration to improve people’s ease of access to quality diabetes information using the Internet.

The American Heart Association (AHA) recently released a scientific statement stating that secondhand cigarette smoke could be harmful to children’s heart health in long-lasting, significant ways, stirring experts to urge leaders to protect children against secondhand smoke.

This week, over 600 cancer survivors, patients and their families -- from almost every congressional district across the U.S. -- will go to Capitol Hill to ask Congress to take action, making the battle against cancer a national priority.

Bayer and Evotec recently formed a partnership to create multiple clinical candidate treatments for kidney diseases, such as chronic kidney disease in diabetes patients, for the next five years.

Acclarent Inc. recently launched its Acclarent Aera Eustachian Tube Balloon Dilation System in the U.S. to treat Eustachian Tube Dysfunction (ETD).